新興生物科技EBS
紐約證券 · USD
4.90
+0.08
(+1.66%)
盤中 08/22 02:05 (UTC+8)
08/22 02:05 (UTC+8)
新興生物科技EBS
4.90
+0.08
(+1.66%)
財務數據
損益表
- 3.00
- 2.55
- 2.94
- 1.95
- 2.22
- 1.41
- 2.31
- 1.44
- 1.56
- 2.34
- 8.60
- -15.21
- 15.35
- -33.73
- 14.12
- -36.59
- 64.02
- -37.78
- 8.55
- 50.10
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 234,300 | 156,100 | 143,800 | 231,100 | 140,900 | 222,200 | 194,700 | 293,800 | 254,700 | 300,400 |
營業成本 | 97,100 | 72,000 | 84,900 | 85,900 | 66,900 | 88,500 | 118,000 | 122,600 | 296,100 | 144,600 |
營業毛利 | 137,200 | 84,100 | 63,800 | 145,200 | 74,000 | 133,700 | 76,700 | 171,200 | -41,400 | 155,800 |
營業費用 | 262,300 | 73,600 | 91,700 | 68,700 | 72,400 | 83,800 | - | - | - | - |
研發費用 | 9,200 | 10,500 | 12,100 | 13,500 | 12,500 | 15,100 | 9,100 | 13,800 | 32,700 | 15,100 |
推銷及管理費用 | 44,600 | 46,600 | 51,100 | 38,900 | 43,700 | 52,400 | 60,800 | 76,600 | 85,900 | 84,700 |
非經常性項目費用 | 191,300 | - | 12,200 | - | - | - | - | - | 27,200 | - |
其他營業費用 | 17,200 | 16,500 | 16,300 | 16,300 | 16,200 | 16,300 | 16,300 | 16,300 | 16,300 | 16,200 |
營業利益 | -125,100 | 10,500 | -15,700 | 76,500 | 1,600 | 49,900 | -9,500 | 64,500 | -203,500 | 39,800 |
其他收入及費用 | -31,200 | 13,900 | -8,100 | -3,700 | -3,700 | 57,500 | -3,300 | 86,200 | -42,700 | -3,400 |
利息費用 | 10,000 | 11,000 | 14,700 | 15,200 | 14,700 | 14,700 | 14,800 | 8,300 | 23,600 | 24,300 |
稅前純益 | -166,300 | 13,400 | -50,700 | 57,600 | -16,800 | 92,700 | -27,600 | 142,400 | -269,800 | 12,100 |
所得稅 | 13,900 | 6,600 | 3,900 | 6,400 | -4,800 | 24,700 | 3,700 | 27,600 | 13,300 | 3,100 |
稅後純益 | -180,200 | 6,800 | -54,600 | 51,200 | -12,000 | 68,000 | -31,300 | 114,800 | -283,100 | 9,000 |
基本每股稅後盈餘(元) | -3.49 | 0.13 | -1.04 | 0.96 | -0.22 | 1.25 | -0.58 | 2.16 | -5.38 | 0.17 |
稀釋每股稅後盈餘(元) | -3.42 | 0.07 | -0.96 | 0.90 | -0.20 | 1.19 | -0.57 | 2.20 | -5.40 | 0.17 |
基本平均股數(千股) | 51600.00 | 51900.00 | 52400.00 | 53200.00 | 54200.00 | 54400.00 | 54200.00 | 53100.00 | 52600.00 | 52200.00 |
稀釋平均股數(千股) | 51600.00 | 56500.00 | 52400.00 | 56500.00 | 54200.00 | 57300.00 | 54200.00 | 55600.00 | 52600.00 | 52200.00 |
還原基本每股稅後盈餘(元) | -3.49 | 0.13 | -1.04 | 0.96 | -0.22 | 1.25 | -0.58 | 2.16 | -5.38 | 0.17 |
還原稀釋每股稅後盈餘(元) | -3.42 | 0.07 | -0.96 | 0.90 | -0.20 | 1.19 | -0.57 | 2.20 | -5.40 | 0.17 |
還原基本平均股數(千股) | 51,600 | 51,900 | 52,400 | 53,200 | 54,200 | 54,400 | 54,200 | 53,100 | 52,600 | 52,200 |
還原稀釋平均股數(千股) | 51,600 | 56,500 | 52,400 | 56,500 | 54,200 | 57,300 | 54,200 | 55,600 | 52,600 | 52,200 |
EBITDA(千元) | -130,700 | 49,700 | -9,900 | 98,700 | 23,800 | 135,100 | 15,400 | 170,400 | -212,700 | 71,200 |